# Objective, MRI biomarkers for pre-symptomatic detection of autism spectrum disorder at 6 months old: commercial software development and optimization

> **NIH NIH R44** · PRIMENEURO, INC. · 2020 · $426,819

## Abstract

There are no changes to the Project Summary/Abstract. An attachment was required to avoid a submission
error.

## Key facts

- **NIH application ID:** 10175793
- **Project number:** 3R44MH118763-02S1
- **Recipient organization:** PRIMENEURO, INC.
- **Principal Investigator:** Bradley A. Bower
- **Activity code:** R44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $426,819
- **Award type:** 3
- **Project period:** 2018-09-18 → 2022-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10175793

## Citation

> US National Institutes of Health, RePORTER application 10175793, Objective, MRI biomarkers for pre-symptomatic detection of autism spectrum disorder at 6 months old: commercial software development and optimization (3R44MH118763-02S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10175793. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*